IV paricalcitol the clear winner in secondary hyperparathyroidism Clinical study 02 February 2013 Pages: 1 - 1
Plans for medical care following natural disasters needed in the US Comment 02 February 2013 Pages: 2 - 2
The National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand have issued guidance on the detection, management and prevention of chronic heart failure Clinical study 02 February 2013 Pages: 3 - 3
Guidelines for the management of basal cell carcinoma (BCC) have been published Guideline 02 February 2013 Pages: 3 - 3
US students call for universities' involvement in drug access crisis Comment 02 February 2013 Pages: 3 - 3
UK NICE has succeeded in reducing variation in patient care, Media release 02 February 2013 Pages: 3 - 3
Higher healthcare and work loss costs with diagnosed uterine leiomyoma Clinical study 02 February 2013 Pages: 5 - 5
Roflumilast appears to be cost saving in the UK among patients with very severe chronic obstructive pulmonary disease Clinical study 02 February 2013 Pages: 5 - 5
ABV “most rational” option for Kaposi's sarcoma in Brazil Clinical study 02 February 2013 Pages: 5 - 5
Metronidazole for trichomoniasis cost-effective HIV prevention Clinical study 02 February 2013 Pages: 6 - 6
Dutch use of antidepressants during pregnancy “alarming” Clinical study 02 February 2013 Pages: 6 - 6
Around 2% of the US population report using dietary supplements containing extracts of Citrus aurantium Clinical study 02 February 2013 Pages: 7 - 7
BP control among Black patients in Nigeria is improving, but is “still unacceptably low”, Clinical study 02 February 2013 Pages: 7 - 7
First-generation antipsychotics get second wind in schizophrenia News item 02 February 2013 Pages: 8 - 8
Biological agents used to treat rheumatoid arthritis (RA) are used by less than 3% of patients as first-line therapy and less than 4% as second-line therapy, despite being approved for first-line use, Media release 02 February 2013 Pages: 8 - 8
Montelukast an advantage for asthma and allergic rhinitis Clinical study 02 February 2013 Pages: 9 - 9
Men with prostate cancer who receive treatment with androgen deprivation therapy experience more symptoms and fatigue than men without the disease, although physical and cognitive function are not affected, Clinical study 02 February 2013 Pages: 9 - 9
Replacing previous antipsychotic therapy with quetiapine improves symptoms and QOL in patients with schizophrenia Clinical study 02 February 2013 Pages: 9 - 9
Add-on omalizumab improves QOL in severe allergic asthma Clinical study 02 February 2013 Pages: 9 - 9
Funds totalling $US200 million, pledged by some of the world's richest nations through the Global Alliance for Vaccines and Immunisations, have been earmarked for the purchase of new-generation rotavirus and pneumococcal vaccines, News item 02 February 2013 Pages: 10 - 10
Lipid-lowering combo drugs to boost cholesterol market in 2007 News item 02 February 2013 Pages: 10 - 10
China is expected to overtake Japan as the world's second largest research and development (R&D) investor by the end of this year, News item 02 February 2013 Pages: 10 - 10
The global market for drugs and devices for managing pain is expected to continue its steady rise between 2006 and 2010, Media release 02 February 2013 Pages: 10 - 10
Delegates from more than 100 countries have initiated discussions on research and development into drugs and other health interventions for diseases disproportionately affecting poorer nations, Media release 02 February 2013 Pages: 10 - 10